reviewJournal of Cellular and Molecular MedicineJun 18, 2019GOLD OA

Immunogenic cell death in cancer therapy: Present and emerging inducers

Shanghai Jiao Tong University · Shanghai Cancer Institute · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

In the tumour microenvironment (TME), immunogenic cell death (ICD) plays a major role in stimulating the dysfunctional antitumour immune system. Chronic exposure of damage-associated molecular patterns (DAMPs) attracts receptors and ligands on dendritic cells (DCs) and activates immature DCs to transition to a mature phenotype, which promotes the processing of phagocytic cargo in DCs and accelerates the engulfment of antigenic components by DCs. Consequently, via antigen presentation, DCs stimulate specific T cell responses that kill more cancer cells. The induction of ICD eventually results in long-lasting protective antitumour immunity. Through the exploration of ICD inducers, recent studies have shown that…

No related works found for this paper.

Funding